Italy

Italy

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.7 (0.40 - 1) 2016 Modelled ECDC
0.5 (0.30 - 1) 2007 Survey/reported Cozzolongo R et al, 2009
0.8 (0.40 - 1.30) 2003 Survey/reported Pendino GM, 2005
0.7 (0 - 3.90) 2001 Survey/reported Floreani A, 2006
1.67 (1.26 - 2.17) 2015 Modelled WHO
0.6 (0.30 - 0.70) 2016 Modelled Razavi-Shearer et al, 2018
2.52 (2.49 - 2.54) 2013 Modelled Schweitzer et al, 2015
0.71 (0.62 - 0.80) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.76 (0.66 - 0.85) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.86) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.88) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.72 - 0.91) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.73 - 0.92) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.75 - 0.94) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.77 - 0.97) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.79 - 0.99) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.81 - 1.01) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.82 - 1.03) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.85 - 1.05) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.88 - 1.08) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.90 - 1.11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.91 - 1.13) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.92 - 1.14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.94 - 1.15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.96 - 1.17) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.98 - 1.19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.99 - 1.21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (1 - 1.22) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (1.03 - 1.25) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (1.06 - 1.29) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (1.09 - 1.32) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (1.11 - 1.34) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (1.12 - 1.36) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.13 - 1.38) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.15 - 1.41) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.18 - 1.44) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.20 - 1.48) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.85) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1 2020 Modelled CDA Foundation
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.61 (0.39 - 0.93) 2015 Modelled WHO
0.03 (0.02 - 0.03) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.04 (0.03 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.11) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.08 - 0.13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.14 - 0.24) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.17 - 0.29) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.20 - 0.35) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.28 - 0.39) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.8 (0.70 - 1) 2016 Modelled ECDC
0.9 (0.70 - 1) 2009 Survey/reported Spada E et al, 2014
0.8 (0.60 - 1) 2012 Survey/reported Ruffini E et al, 2014
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
6.7 (5.20 - 8.40) 2002 Survey/reported Babudieri S et al, 2005
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
332,000 (202,000 - 430,000) 2016 Modelled Razavi-Shearer et al, 2018
430,090 (375,354 - 483,967) 2019 Modelled IHME, GBD 2019 (accessed 2020)
439,721 (384,369 - 495,502) 2019 Modelled IHME, GBD 2019 (accessed 2022)
441,741 (385,899 - 497,174) 2018 Modelled IHME, GBD 2019 (accessed 2022)
443,503 (387,293 - 498,306) 2017 Modelled IHME, GBD 2019 (accessed 2022)
458,918 (401,987 - 513,137) 2016 Modelled IHME, GBD 2019 (accessed 2022)
475,434 (418,888 - 528,429) 2015 Modelled IHME, GBD 2019 (accessed 2022)
481,465 (424,356 - 534,668) 2014 Modelled IHME, GBD 2019 (accessed 2022)
492,970 (434,891 - 547,159) 2013 Modelled IHME, GBD 2019 (accessed 2022)
506,696 (447,869 - 560,975) 2012 Modelled IHME, GBD 2019 (accessed 2022)
518,933 (459,120 - 574,897) 2011 Modelled IHME, GBD 2019 (accessed 2022)
525,494 (466,440 - 583,723) 2010 Modelled IHME, GBD 2019 (accessed 2022)
531,282 (473,293 - 588,571) 2009 Modelled IHME, GBD 2019 (accessed 2022)
541,662 (484,181 - 598,770) 2008 Modelled IHME, GBD 2019 (accessed 2022)
553,539 (495,660 - 611,375) 2007 Modelled IHME, GBD 2019 (accessed 2022)
563,654 (504,798 - 623,636) 2006 Modelled IHME, GBD 2019 (accessed 2022)
568,198 (508,040 - 628,390) 2005 Modelled IHME, GBD 2019 (accessed 2022)
570,523 (511,719 - 629,477) 2004 Modelled IHME, GBD 2019 (accessed 2022)
576,132 (517,145 - 635,826) 2003 Modelled IHME, GBD 2019 (accessed 2022)
583,861 (524,542 - 643,464) 2002 Modelled IHME, GBD 2019 (accessed 2022)
591,359 (531,446 - 650,153) 2001 Modelled IHME, GBD 2019 (accessed 2022)
596,054 (536,025 - 655,866) 2000 Modelled IHME, GBD 2019 (accessed 2022)
603,806 (542,915 - 664,011) 1999 Modelled IHME, GBD 2019 (accessed 2022)
619,101 (558,596 - 679,650) 1998 Modelled IHME, GBD 2019 (accessed 2022)
637,413 (576,660 - 697,192) 1997 Modelled IHME, GBD 2019 (accessed 2022)
654,156 (591,933 - 715,070) 1996 Modelled IHME, GBD 2019 (accessed 2022)
664,623 (600,488 - 727,822) 1995 Modelled IHME, GBD 2019 (accessed 2022)
672,531 (607,644 - 736,655) 1994 Modelled IHME, GBD 2019 (accessed 2022)
684,165 (616,294 - 750,830) 1993 Modelled IHME, GBD 2019 (accessed 2022)
698,366 (628,952 - 767,565) 1992 Modelled IHME, GBD 2019 (accessed 2022)
713,941 (641,960 - 786,075) 1991 Modelled IHME, GBD 2019 (accessed 2022)
729,702 (653,248 - 806,083) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.84 (2.52 - 3.19) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.03 (4.55 - 5.52) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.83 (4.37 - 5.31) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (4.13 - 5.04) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.99 - 4.87) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.78 - 4.60) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.3 (3.88 - 4.74) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.74 - 4.56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.74 - 4.55) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.14 (3.75 - 4.55) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.73 - 4.55) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.66 - 4.46) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (3.39 - 4.12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (3.53 - 4.30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (3.21 - 3.93) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.34 (3 - 3.69) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.19 (2.87 - 3.55) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.07 (2.76 - 3.41) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.96 (2.66 - 3.29) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.58 - 3.20) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.81 (2.53 - 3.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.48 - 3.08) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.48 - 3.07) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.47 - 3.07) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (2.42 - 3.03) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.39 - 2.99) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.33 - 2.92) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.39 - 3.03) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.41 - 3.02) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.46 - 3.12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.84 (2.52 - 3.19) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,509 2016 Modelled WHO
2,854 (2,583 - 3,134) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,741 (2,481 - 3,012) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,595 (2,345 - 2,857) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,432 (2,196 - 2,679) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,500 (2,261 - 2,758) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,362 (2,136 - 2,600) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,333 (2,111 - 2,573) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,336 (2,117 - 2,569) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,330 (2,109 - 2,568) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,334 (2,111 - 2,572) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,290 (2,072 - 2,525) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,137 (1,934 - 2,355) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,219 (2,008 - 2,446) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,048 (1,845 - 2,257) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,933 (1,737 - 2,137) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,863 (1,673 - 2,069) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,755 (1,574 - 1,946) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,805 (1,619 - 2,004) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,689 (1,518 - 1,881) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,716 (1,540 - 1,906) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,668 (1,500 - 1,860) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,669 (1,499 - 1,858) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,670 (1,498 - 1,862) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,645 (1,474 - 1,841) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,587 (1,413 - 1,773) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,626 (1,452 - 1,818) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,643 (1,465 - 1,834) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,633 (1,451 - 1,836) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,676 (1,488 - 1,884) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,714 (1,517 - 1,927) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,714 (1,517 - 1,927) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
13 (11 - 15) 1990 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1991 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1992 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 16) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1997 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1996 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 13) 2003 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2019 Survey/reported WHO/UNICEF
94 2020 Survey/reported WHO/UNICEF
94 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Proportion of persons living with HBV diagnosed

National
Download
Value (%) Year Type Source
29 2016 Modelled CDA Foundation

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
30 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HBV testing policy
None
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.1 (0.70 - 1.30) 2015 Modelled Blach et al, 2017
1.87 (1.51 - 2.30) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.51 - 2.28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.50 - 2.26) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.48 - 2.22) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.46 - 2.18) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.48 - 2.21) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (1.53 - 2.29) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.96 (1.60 - 2.39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.65 - 2.48) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.69 - 2.52) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.70 - 2.53) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.70 - 2.52) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.70 - 2.52) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.71 - 2.52) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.72 - 2.52) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.14 (1.75 - 2.58) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.84 - 2.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.35 (1.93 - 2.82) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (2 - 2.93) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (2.03 - 2.98) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (2.03 - 2.99) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (2.03 - 2.99) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (2.02 - 2.99) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (2.01 - 2.98) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (1.99 - 2.95) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.39 (1.96 - 2.90) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.90 - 2.81) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.83 - 2.70) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.74 - 2.57) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.64 - 2.43) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.44 - 2.19) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.68 (0.54 - 0.82) 2020 Modelled Kondili et al, 2022
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.39 (0.38 - 0.40) 2018 Survey/reported Piffer et al, 2020
People who inject drugs (PWID)
Download
Value (%) Year Type Source
56.61 2016 Survey/reported EMCDDA
57.26 2015 Survey/reported EMCDDA
54 2014 Survey/reported EMCDDA
49.6 2013 Survey/reported EMCDDA
67.52 2012 Survey/reported EMCDDA
60.48 2010 Survey/reported EMCDDA
58.52 2009 Survey/reported EMCDDA
59.24 2008 Survey/reported EMCDDA
60.21 2007 Survey/reported EMCDDA
61.95 2006 Survey/reported EMCDDA
61.4 2005 Survey/reported EMCDDA
63.5 2004 Survey/reported EMCDDA
64.9 2003 Survey/reported EMCDDA
64.89 2002 Survey/reported EMCDDA
66.32 2001 Survey/reported EMCDDA
67.4 2000 Survey/reported EMCDDA
67.14 1999 Survey/reported EMCDDA
67.45 1998 Survey/reported EMCDDA
67.1 1997 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.65 (0.44 - 1.58) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
5.9 (5.20 - 6.60) 2016 Modelled ECDC
2.6 (2 - 3.40) 2007 Survey/reported Cozzolongo R et al, 2009
6.5 (5.40 - 7.80) 2003 Survey/reported Pendino GM, 2005
10.2 (8 - 12.70) 2001 Survey/reported Floreani A, 2006
2 (1.60 - 7.30) 2014 Survey/reported Gower et al, 2014
2.43 2019 Modelled Jin et al. 2017
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.4 (0.30 - 0.50) 2012 Survey/reported Ruffini E et al, 2014
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
4.4 (2.10 - 7.20) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
57.9 (52.50 - 63.30) 2014 Modelled Degenhardt L et al, 2017
60.5 (56.80 - 64) 2010 Survey/reported EMCDDA
64.33 2017 Survey/reported ECDC
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
64.3 2017 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2.6 2019 Modelled Jin et al. 2017
Prisoners
Download
Value (%) Year Type Source
38 (35 - 41.20) 2002 Survey/reported Babudieri S et al, 2005
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
680,000 (455,000 - 1,641,000) 2015 Modelled Blach et al, 2017
1,093,900 (897,393 - 1,329,570) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,157,250 (946,954 - 1,402,000) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,214,640 (996,202 - 1,468,060) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,263,390 (1,036,430 - 1,528,880) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,300,570 (1,064,350 - 1,573,030) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,323,380 (1,081,360 - 1,600,160) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,335,800 (1,091,000 - 1,616,140) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,343,370 (1,096,910 - 1,623,860) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,347,130 (1,100,360 - 1,622,780) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,348,300 (1,101,750 - 1,622,010) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,348,100 (1,102,000 - 1,622,920) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,328,980 (1,087,700 - 1,599,910) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,283,040 (1,052,370 - 1,545,670) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,228,000 (1,008,830 - 1,482,300) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,182,630 (970,869 - 1,427,460) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,164,400 (956,405 - 1,407,180) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,168,340 (959,118 - 1,414,540) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,176,140 (961,936 - 1,427,070) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,184,860 (968,904 - 1,438,210) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,191,660 (973,113 - 1,448,220) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,193,460 (973,720 - 1,457,500) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,176,420 (959,232 - 1,433,930) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,138,150 (927,387 - 1,388,430) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,093,320 (890,300 - 1,330,310) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,057,350 (860,264 - 1,284,440) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,045,250 (850,828 - 1,269,380) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,061,770 (865,680 - 1,295,290) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,081,010 (878,737 - 1,319,930) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,087,730 (883,104 - 1,334,120) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,088,890 (883,078 - 1,335,280) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,074,970 (869,359 - 1,320,490) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
81,800 (54,700 - 197,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
13.3 (11.80 - 14.70) 2019 Modelled IHME, GBD 2019 (accessed 2020)
15.38 (14.17 - 16.63) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15.67 (14.42 - 16.93) 1991 Modelled IHME, GBD 2019 (accessed 2022)
15.77 (14.47 - 17.04) 1992 Modelled IHME, GBD 2019 (accessed 2022)
15.95 (14.68 - 17.23) 1993 Modelled IHME, GBD 2019 (accessed 2022)
16.08 (14.82 - 17.32) 1994 Modelled IHME, GBD 2019 (accessed 2022)
15.84 (14.61 - 17.13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
15.69 (14.46 - 16.96) 1996 Modelled IHME, GBD 2019 (accessed 2022)
15.53 (14.31 - 16.77) 1997 Modelled IHME, GBD 2019 (accessed 2022)
15.41 (14.24 - 16.70) 1998 Modelled IHME, GBD 2019 (accessed 2022)
15.29 (14.14 - 16.52) 1999 Modelled IHME, GBD 2019 (accessed 2022)
14.97 (13.83 - 16.20) 2000 Modelled IHME, GBD 2019 (accessed 2022)
14.27 (13.07 - 15.46) 2002 Modelled IHME, GBD 2019 (accessed 2022)
14.63 (13.46 - 15.81) 2001 Modelled IHME, GBD 2019 (accessed 2022)
13.76 (12.56 - 14.92) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13.16 (11.94 - 14.37) 2004 Modelled IHME, GBD 2019 (accessed 2022)
12.66 (11.43 - 13.85) 2006 Modelled IHME, GBD 2019 (accessed 2022)
12.84 (11.60 - 14.02) 2005 Modelled IHME, GBD 2019 (accessed 2022)
12.63 (11.38 - 13.80) 2007 Modelled IHME, GBD 2019 (accessed 2022)
12.74 (11.44 - 13.91) 2008 Modelled IHME, GBD 2019 (accessed 2022)
12.88 (11.54 - 14.05) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12.85 (11.49 - 14.01) 2009 Modelled IHME, GBD 2019 (accessed 2022)
12.98 (11.60 - 14.16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
13.04 (11.62 - 14.23) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12.86 (11.46 - 14.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12.74 (11.34 - 13.93) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12.85 (11.39 - 14.06) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12.4 (11.01 - 13.57) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12.74 (11.32 - 14) 2017 Modelled IHME, GBD 2019 (accessed 2022)
13.07 (11.59 - 14.33) 2018 Modelled IHME, GBD 2019 (accessed 2022)
13.35 (11.77 - 14.68) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
10,470 2016 Modelled WHO
8,050 (7,096 - 8,856) 2019 Modelled IHME, GBD 2019 (accessed 2022)
8,050 (7,096 - 8,856) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7,905 (7,007 - 8,662) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7,719 (6,858 - 8,483) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7,523 (6,682 - 8,238) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7,811 (6,923 - 8,542) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7,748 (6,896 - 8,468) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7,816 (6,969 - 8,542) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7,919 (7,057 - 8,637) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7,861 (7,027 - 8,576) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7,772 (6,962 - 8,476) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7,709 (6,897 - 8,410) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7,596 (6,822 - 8,292) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7,477 (6,734 - 8,167) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7,436 (6,715 - 8,140) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7,486 (6,767 - 8,179) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7,614 (6,909 - 8,313) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7,904 (7,211 - 8,568) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8,149 (7,465 - 8,829) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8,318 (7,651 - 8,992) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8,485 (7,839 - 9,180) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8,644 (7,994 - 9,338) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8,703 (8,043 - 9,427) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8,768 (8,078 - 9,466) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8,857 (8,161 - 9,577) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8,950 (8,257 - 9,679) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9,097 (8,384 - 9,798) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9,036 (8,315 - 9,759) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8,945 (8,204 - 9,662) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8,894 (8,187 - 9,612) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8,734 (8,050 - 9,446) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
59 (54 - 64) 1990 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 1991 Modelled IHME, GBD 2019 (accessed 2022)
63 (58 - 69) 1992 Modelled IHME, GBD 2019 (accessed 2022)
68 (62 - 73) 1994 Modelled IHME, GBD 2019 (accessed 2022)
66 (60 - 72) 1993 Modelled IHME, GBD 2019 (accessed 2022)
67 (61 - 72) 1995 Modelled IHME, GBD 2019 (accessed 2022)
67 (61 - 73) 1996 Modelled IHME, GBD 2019 (accessed 2022)
67 (61 - 72) 1997 Modelled IHME, GBD 2019 (accessed 2022)
66 (60 - 71) 1998 Modelled IHME, GBD 2019 (accessed 2022)
68 (62 - 73) 1999 Modelled IHME, GBD 2019 (accessed 2022)
68 (62 - 73) 2000 Modelled IHME, GBD 2019 (accessed 2022)
66 (60 - 72) 2001 Modelled IHME, GBD 2019 (accessed 2022)
64 (58 - 70) 2002 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 2004 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 2003 Modelled IHME, GBD 2019 (accessed 2022)
59 (53 - 64) 2005 Modelled IHME, GBD 2019 (accessed 2022)
59 (53 - 64) 2006 Modelled IHME, GBD 2019 (accessed 2022)
60 (54 - 64) 2008 Modelled IHME, GBD 2019 (accessed 2022)
59 (52 - 63) 2007 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 2009 Modelled IHME, GBD 2019 (accessed 2022)
64 (57 - 69) 2010 Modelled IHME, GBD 2019 (accessed 2022)
65 (58 - 71) 2011 Modelled IHME, GBD 2019 (accessed 2022)
66 (59 - 72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
66 (59 - 72) 2013 Modelled IHME, GBD 2019 (accessed 2022)
66 (58 - 72) 2014 Modelled IHME, GBD 2019 (accessed 2022)
63 (56 - 69) 2015 Modelled IHME, GBD 2019 (accessed 2022)
61 (53 - 66) 2016 Modelled IHME, GBD 2019 (accessed 2022)
62 (55 - 69) 2017 Modelled IHME, GBD 2019 (accessed 2022)
62 (55 - 69) 2018 Modelled IHME, GBD 2019 (accessed 2022)
63 (55 - 69) 2019 Modelled IHME, GBD 2019 (accessed 2022)
58 (54 - 62) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons initiating HCV treatment

National
Download
Value Year Type Source
30,161 2015 Survey/reported Agenzia Italiana el Farmaco, 2023
34,066 2016 Survey/reported Agenzia Italiana el Farmaco, 2024
44,660 2017 Survey/reported Agenzia Italiana el Farmaco, 2025
56,499 2018 Survey/reported Agenzia Italiana el Farmaco, 2026
36,348 2019 Survey/reported Agenzia Italiana el Farmaco, 2027
15,664 2020 Survey/reported Agenzia Italiana el Farmaco, 2028
14,481 2021 Survey/reported Agenzia Italiana el Farmaco, 2029
Showing out of
Show more

Cumulative number of persons treated for HCV

National (2015-2021)
Download
Value Year Type Source
231,879 2021 Survey/reported Agenzia Italiana el Farmaco, 2022

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
30 2017 Survey/reported EMCDDA, 2019

Proportion of persons living with HCV diagnosed

National
Download
Value (%) Year Type Source
44 2020 Modelled CDA Foundation
HBV National Action Plan
HBV elimination goal
HBV testing policy
None
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
1,714
2019
(1,517 - 1,927)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
8,050
2019
(7,096 - 8,856)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources